# Dr. Agarwals Health Care Ltd (AGARWALEYE)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹481.1
Day Change: +4.66%
52W High: ₹568
52W Low: ₹327
Market Cap: ₹14,010 Cr

## Valuation
P/E: 111.62
P/B: 7.23
EPS: ₹3.96
Book Value: ₹61.13
Dividend Yield: 0%

## Returns
1Y Return: -10.59%

## Profitability
ROE: 0%
ROCE: 35.32%
Debt/Equity: 0.49
Revenue Growth: 23%
Profit Growth: 47.2%
EBITDA Margin: 23.85%
Operating Margin: 14.22%

## About
Dr. Agarwals Health Care Ltd is a Medical Instruments & Supplies company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Sub Industry: Unknown

## Business Model
Overview: Dr. Agarwals Health Care Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 24/7 Wall St.: We’re in our 40s with a healthy portfolio: how a $1.3 million tax bomb forced us to act before retirement

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:00.502Z
Price History Updated: 2026-05-17T21:23:54.416Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:23:54.416Z
Quant Updated: 2026-05-17T21:23:54.416Z
Sentiment Updated: 2026-05-17T21:23:54.416Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:10.843Z
Financials Last Attempt: 2026-05-18T10:30:10.843Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹531 Cr
Operating Profit: ₹124 Cr (OPM 23%)
Net Profit: ₹-21 Cr
Tax: ₹-11 Cr

## Annual P&L History
Mar 2021: Rev ₹531Cr | PAT ₹-21Cr | OPM 23%
Mar 2022: Rev ₹471Cr | PAT ₹-59Cr | OPM 18%
Mar 2023: Rev ₹696Cr | PAT ₹43Cr | OPM 27%

## Balance Sheet (Mar 2021)
Total Assets: ₹751 Cr
Total Liabilities: ₹751 Cr
Borrowings: ₹162 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Adil  Agarwal M.B.B.S, M.S, MBA, CEO & Whole-Time Director
- Yashwanth  Venkat, Chief Financial Officer
- Anosh  Agarwal M.B.B.S, MBA, MS Ophthal, COO & Wholetime Director
- Thanikainathan  Arumugam, VP of Corporate Affairs, Company Secretary & Compliance Officer
- Ashvin  Agarwal, Chief Clinical Officer

---
Source: rupiya.io/stocks/agarwaleye
Disclaimer: For research and education only. Not investment advice.